Real World Analysis of the Efficacy, Prognosis and Safety of Daratumumab, Carfilzomib, and Dexamethasone (DKD) in Relapsed or Refractory Multiple Myeloma Patients

被引：0

作者：

Fu, Chengcheng ^{[1
]}

You, Hongying ^{[1
]}

Jin, Song ^{[1
]}

Wang, Panfeng ^{[2
]}

Yan, Lingzhi ^{[1
]}

Zhang, Liying ^{[3
]}

Lu, Tingting ^{[4
]}

Gao, Xiao ^{[5
]}

Jiang, Lei ^{[6
]}

Qiu, Hongchun ^{[7
]}

Shang, Jingjing ^{[1
]}

Zhai, Yingying ^{[1
]}

Yao, Weiqin ^{[1
]}

Yan, Shuang ^{[1
]}

Yan, Zhi ^{[1
]}

Wu, Depei ^{[1
]}

机构：

[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China

[2] Soochow Hopes Hematonosis Hosp, Suzhou, Peoples R China

[3] Soochow Univ, Affiliated Hosp 2, Suzhou, Peoples R China

[4] Soochow Univ, Zhangjiagang Hosp, Suzhou, Peoples R China

[5] Zhangjiagang Hosp Tradit Chinese Med, Suzhou, Peoples R China

[6] Soochow Univ, Suzhou Hosp 9, Suzhou, Peoples R China

[7] Third Peoples Hosp Kunshan, Dept Hematol, Kunshan, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-210102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6992 / 6993

页数：2

共 50 条

[21] Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
Onda, Yoshiyuki
Kanda, Junya
Kaneko, Hitomi
Shimura, Yuji
Fuchida, Shin-ichi
Nakaya, Aya
Itou, Tomoki
Yamamura, Ryosuke
Tanaka, Hirokazu
Shibayama, Hirohiko
Shimazu, Yutaka
Uchiyama, Hitoji
Yoshihara, Satoshi
Adachi, Yoko
Matsuda, Mitsuhiro
Hanamoto, Hitoshi
Uoshima, Nobuhiko
Kosugi, Satoru
Ohta, Kensuke
Yagi, Hideo
Kanakura, Yuzuru
Matsumura, Itaru
Hino, Masayuki
Nomura, Shosaku
Shimazaki, Chihiro
Takaori-Kondo, Akifumi
Kuroda, Junya
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
[22] The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma
Jeon, Min Ji
Yu, Eun Sang
Kang, Ka-Won
Lee, Byung-Hyun
Park, Yong
Lee, Se Ryeon
Sung, Hwa Jung
Choi, Chul Won
Kim, Byung Soo
Kim, Dae Sik
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E260 - E261
[23] The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma
贾亚静
China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 189 - 189
[24] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
Szilvia Lovas
Gergely Varga
Péter Farkas
Tamás Masszi
Nikolett Wohner
Ágnes Bereczki
Nóra Adamkovich
Zita Borbényi
Árpád Szomor
Hussain Alizadeh
Erika Szaleczky
Krisztina Wolf
Tamás Schneider
Márk Plander
Tamás Szendrei
Ottó Csacsovszki
Zoltán Csukly
Péter Rajnics
Miklós Egyed
Zsolt Nagy
László Rejtő
Árpád Illés
Gábor Mikala
László Váróczy
International Journal of Hematology, 2019, 110 : 559 - 565
[25] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
Lovas, Szilvia
Varga, Gergely
Farkas, Peter
Masszi, Tamas
Wohner, Nikolett
Bereczki, Agnes
Adamkovich, Nora
Borbenyi, Zita
Szomor, Arpad
Alizadeh, Hussain
Szaleczky, Erika
Wolf, Krisztina
Schneider, Tamas
Plander, Mark
Szendrei, Tamas
Csacsovszki, Otto
Csukly, Zoltan
Rajnics, Peter
Egyed, Miklos
Nagy, Zsolt
Rejto, Laszlo
Illes, Arpad
Mikala, Gabor
Varoczy, Laszlo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) : 559 - 565
[26] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study
Kim, Do Young
Shin, Ho-Jin
Min, Chang-Ki
Eom, Hyeon-Seok
Jung, Jongheon
Kim, Kihyun
Lee, Jae Hoon
Yoo, Kwai Han
Lee, Ji Yun
Byun, Ja Min
Kim, Sung-Hyun
Lee, Ji Hyun
Cho, Hee Jeong
Lee, Sang Min
Do, Young Rok
Park, Sungwoo
Lee, Junglim
Lee, Seung-Shin
Kang, Hye Jin
Park, Young Hoon
Lim, Sung-Nam
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S189 - S190
[27] Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Moreau, Philippe
Chari, Ajai
Oriol, Albert
Martinez-Lopez, Joaquin
Haenel, Mathias
Touzeau, Cyrille
Ailawadhi, Sikander
Besemer, Britta
de la Rubia Comos, Javier
Encinas, Cristina
Mateos, Maria-Victoria
Salwender, Hans
Rodriguez-Otero, Paula
Hulin, Cyrille
Karlin, Lionel
Sureda Balari, Anna
Bargay, Joan
Benboubker, Lotfi
Rosinol, Laura
Tarantolo, Stefano
Terebelo, Howard
Yang, Shiyi
Wang, Jianping
Nnane, Ivo
Qi, Ming
Kosh, Michele
Delioukina, Maria
Goldschmidt, Hartmut
BLOOD CANCER JOURNAL, 2023, 13 (01)
[28] Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Philippe Moreau
Ajai Chari
Albert Oriol
Joaquin Martinez-Lopez
Mathias Haenel
Cyrille Touzeau
Sikander Ailawadhi
Britta Besemer
Javier de la Rubia Comos
Cristina Encinas
Maria-Victoria Mateos
Hans Salwender
Paula Rodriguez-Otero
Cyrille Hulin
Lionel Karlin
Anna Sureda Balari
Joan Bargay
Lotfi Benboubker
Laura Rosiñol
Stefano Tarantolo
Howard Terebelo
Shiyi Yang
Jianping Wang
Ivo Nnane
Ming Qi
Michele Kosh
Maria Delioukina
Hartmut Goldschmidt
Blood Cancer Journal, 13
[29] Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Gasparetto, Cristina
Lentzsch, Suzanne
Schiller, Gary
Callander, Natalie
Tuchman, Sascha
Chen, Christine
White, Darrell
Kotb, Rami
Sutherland, Heather
Sebag, Michael
Baljevic, Muhamed
Bensinger, William
Leblanc, Richard
Venner, Chris
Bahlis, Nizar
Rossi, Adriana
Biran, Noa
Sheehan, Heidi
Saint-Martin, Jean-Richard
Van Domelen, Dane
Kai, Kazuharu
Shah, Jatin
Shacham, Sharon
Kauffman, Michael
Lipe, Brea
EJHAEM, 2021, 2 (01): : 56 - 65
[30] Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
De Novellis, Danilo
Derudas, Daniele
Vincelli, Donatella
Fontana, Raffaele
Della Pepa, Roberta
Palmieri, Salvatore
Accardi, Fabrizio
Rotondo, Francesco
Morelli, Emanuela
Gigliotta, Emilia
Roccotelli, Daniela
Marano, Luana
Barone, Maria Lucia
Cetani, Giusy
Esposito, Daniela
Lazzaro, Antonio
Delle Cave, Giuseppe
Serio, Bianca
Morini, Denise
Porrazzo, Marika
Urciuoli, Eleonora
Masucci, Chiara
Fanelli, Fulvia
Rizzo, Michela
Arcamone, Manuela
Trastulli, Fabio
Rocco, Stefano
Leone, Aldo
Bianco, Rosario
Salvatore, Flavia
Idato, Aurora
Sicari, Maria
Tosi, Patrizia
Rascato, Maria Gabriella
Di Perna, Maria
Falcone, Antonietta Pia
Morello, Lucia
Carlisi, Melania
Svanera, Gino
Annunziata, Mario
Frigeri, Ferdinando
Califano, Catello
Carella, Angelo Michele
Marcacci, Gianpaolo
Pane, Fabrizio
Risitano, Antonio Maria
Giudice, Valentina
Botta, Ciro
Selleri, Carmine
EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 105 - 114

← 1 2 3 4 5 →